Health Care
Commentary
American Healthcare Broken? Says Who?
A new study from the Commonwealth Fund ranks the U.S. health system dead last among 10 developed nations. But is healthcare in the United States really that bad? A close look at the data suggests otherwise. Read the full article in Newsmax.
Sally C. Pipes
October 1, 2024
Biosimilars
The Biosimilar Promise
Biosimilars Often Reduce Prices by 50 Percent or More
Biosimilars Often Reduce Prices by 50 Percent or More By Wayne Winegarden | October 1, 2024 READ PDF Executive Summary In the competitive biologic markets, biosimilars have reduced average prices by 56 percent. The lower prices have reduced total expenditures by 51 percent in the competitive biologic markets even though ...
Wayne H Winegarden
October 1, 2024
Commentary
A British Lord’s Warning: Steer Clear of Single-Payer Healthcare
Two hundred and fifty years ago, a group of Americans sounded the alarm about the oppressive government policies being propagated by British lords. Today, the tables have turned. This month, Lord Ara Darzi presented the United Kingdom’s Secretary of State for Health and Social Care with a devastating report on the state ...
Sally C. Pipes
September 30, 2024
Commentary
Women, Children, Disabled Pay The Price For Obamacare’s Medicaid Expansion
Obamacare greatly expanded Medicaid eligibility. As a result, about 20 million able-bodied, working-age adults who were previously ineligible are now enrolled in the program. But as a new report from the Paragon Health Institute makes clear, their gains have come at the expense of the pregnant women, children, and people ...
Sally C. Pipes
September 25, 2024
Climate Change
Learn how municipal climate change lawsuits hurt consumers
Bonta’s legal war on energy companies will punish ordinary Californians
Neither are heroic efforts to safeguard the environment. The former will primarily harm families by worsening the nation’s pervasive affordability problems. The second is a clear effort to extract “multiple billions” from ExxonMobil while maximizing political optics in a state where the majority of voters will support anything they are ...
Wayne Winegarden and Kerry Jackson
September 25, 2024
Commentary
Learn how PBMs pocket savings intended for patients
How Long Can Pharmacy Benefit Managers Go Unchecked?
Last week, a House subcommittee held a hearing on pharmacy benefit managers and their impact on the prices patients pay for prescription drugs. The hearing speaks to voters’ concerns. Republicans and Democrats alike have identified the cost of prescription drugs as their No. 2 health care concern, according to polling ...
Sally C. Pipes
September 24, 2024
Commentary
Read about the Trump and Harris health care plans
Trump Has a Plan for Healthcare
Harris, by contrast, has been mum on whether she continues to support a government takeover of the health insurance system as she did during her first run for the presidency. Instead, she has said that she wants to strengthen the Affordable Care Act and extend President Joe Biden’s ruinously expensive scheme ...
Sally C. Pipes
September 20, 2024
Commentary
Learn about the latest problems with Obamacare
Americans Don’t Want Obamacare’s High Maintenance
At last week’s presidential debate, Vice President Kamala Harris was asked about her previous support for Medicare For All, a $44 trillion proposal that would outlaw private insurance. She backed away from the questions, saying, “What we need to do is maintain and grow the Affordable Care Act.” Read the full ...
Sally C. Pipes
September 18, 2024
Blog
Learn how drug price controls hurt patients, innovation
Senator Sanders’ Price Controls Will Harm Patients
In a patently politicized press release, Senator Bernie Sanders (I-VT) who is Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, claims that the U.S. price of Ozempic is too high. As evidence, he cites generic companies that claim they can sell Ozempic for less than $100 a ...
Wayne Winegarden
September 18, 2024
Commentary
Drug Companies Are Embracing Direct-To-Consumer Sales. That’s A Win For Patients.
Fortunately, that’s starting to change. In recent months, drug companies Pfizer and Eli Lilly have begun rolling out direct-to-consumer programs that let patients purchase basic prescriptions remotely. This development is a huge win for patients. Not only are direct-to-consumer offerings more convenient. They can also provide a jolt of competition ...
Sally C. Pipes
September 16, 2024
American Healthcare Broken? Says Who?
A new study from the Commonwealth Fund ranks the U.S. health system dead last among 10 developed nations. But is healthcare in the United States really that bad? A close look at the data suggests otherwise. Read the full article in Newsmax.
The Biosimilar Promise
Biosimilars Often Reduce Prices by 50 Percent or More
Biosimilars Often Reduce Prices by 50 Percent or More By Wayne Winegarden | October 1, 2024 READ PDF Executive Summary In the competitive biologic markets, biosimilars have reduced average prices by 56 percent. The lower prices have reduced total expenditures by 51 percent in the competitive biologic markets even though ...
A British Lord’s Warning: Steer Clear of Single-Payer Healthcare
Two hundred and fifty years ago, a group of Americans sounded the alarm about the oppressive government policies being propagated by British lords. Today, the tables have turned. This month, Lord Ara Darzi presented the United Kingdom’s Secretary of State for Health and Social Care with a devastating report on the state ...
Women, Children, Disabled Pay The Price For Obamacare’s Medicaid Expansion
Obamacare greatly expanded Medicaid eligibility. As a result, about 20 million able-bodied, working-age adults who were previously ineligible are now enrolled in the program. But as a new report from the Paragon Health Institute makes clear, their gains have come at the expense of the pregnant women, children, and people ...
Learn how municipal climate change lawsuits hurt consumers
Bonta’s legal war on energy companies will punish ordinary Californians
Neither are heroic efforts to safeguard the environment. The former will primarily harm families by worsening the nation’s pervasive affordability problems. The second is a clear effort to extract “multiple billions” from ExxonMobil while maximizing political optics in a state where the majority of voters will support anything they are ...
Learn how PBMs pocket savings intended for patients
How Long Can Pharmacy Benefit Managers Go Unchecked?
Last week, a House subcommittee held a hearing on pharmacy benefit managers and their impact on the prices patients pay for prescription drugs. The hearing speaks to voters’ concerns. Republicans and Democrats alike have identified the cost of prescription drugs as their No. 2 health care concern, according to polling ...
Read about the Trump and Harris health care plans
Trump Has a Plan for Healthcare
Harris, by contrast, has been mum on whether she continues to support a government takeover of the health insurance system as she did during her first run for the presidency. Instead, she has said that she wants to strengthen the Affordable Care Act and extend President Joe Biden’s ruinously expensive scheme ...
Learn about the latest problems with Obamacare
Americans Don’t Want Obamacare’s High Maintenance
At last week’s presidential debate, Vice President Kamala Harris was asked about her previous support for Medicare For All, a $44 trillion proposal that would outlaw private insurance. She backed away from the questions, saying, “What we need to do is maintain and grow the Affordable Care Act.” Read the full ...
Learn how drug price controls hurt patients, innovation
Senator Sanders’ Price Controls Will Harm Patients
In a patently politicized press release, Senator Bernie Sanders (I-VT) who is Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, claims that the U.S. price of Ozempic is too high. As evidence, he cites generic companies that claim they can sell Ozempic for less than $100 a ...
Drug Companies Are Embracing Direct-To-Consumer Sales. That’s A Win For Patients.
Fortunately, that’s starting to change. In recent months, drug companies Pfizer and Eli Lilly have begun rolling out direct-to-consumer programs that let patients purchase basic prescriptions remotely. This development is a huge win for patients. Not only are direct-to-consumer offerings more convenient. They can also provide a jolt of competition ...